Genmab — Februar 2023
-
Driften påvirkes ikke af den igangværende sag, hvis det bliver det totale nederlag. Hvad kursen vil falde, vil afhænge af hvor meget markedet har indregnet og det kan godt være nul eller mere/mindre. Aktien kan også falde mere end markedet har indregnet, hvis køen ved udgangen bliver tilstrækkelig stor i et kort tidsrum.
-
Vi har vel ikke glemt solide "nyheden" omkring 2018/19... den har snart fortabt sig tågen.
-
Jan lægger på +40 mio. i 2022 og med en tabt voldgift i baggagen i årets l
, så syns jeg det er voldsomt. -
Voldsomt er måske "voldsomt" at bruge .... men det er hvert fald en flot løn, taget årets begivenheder in mente. Nuvel væksten er god, men voldgiften har potentialet kostet 12-13 % af +100-120 mia. kr. Mindes ikke Novo nogensinde har leveret samme streg i regningen
-
Så tror jeg, at jeg har udtrykt mig til strækkeligt om lønninger og det forhold, at øget (US) lønniveau ikke er en nødvendig forudsætning for, at tiltrække dygtige medarbejdere og skabe store succes. Slut herfra, for i dag
-
I started 01.01.2023,
-
For the first time, we report a successful approach to the treatment of refractory anti-NMDAR encephalitis
using the fully human anti-CD20 monoclonal antibody ofatumumab, which serves as an important
reference for the treatment of autoimmune encephalitis. In our cases, satisfactory clinical outcomes were still observed in anti-NMDR encephalitis
while first-line therapy failed. Thus, the case report provides reference for new treatment options of
autoimmune encephalitis -
Our Alem-Ofa dual-targeted immunotherapy study showed that it is an early example of a chemotherapy-free treatment option with several advantages even in the modern treatment era. First the treatment is of a limited and short duration of no longer than 4.5 months. Second, it was able to achieve rapid onset, deep and durable response; most patients needed no additional therapy in the next five years.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind